FindTrial
Sign In

Prediction of microvascular invasion in hbv-hcc patients based on peripheral blood MicroRNA

Prediction of microvascular invasion in hbv-hcc patients based on peripheral blood MicroRNA

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022843
Enrollment
Unknown
Registered
2019-04-28
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hbv associated hepatocellular carcinoma

Interventions

Gold Standard:pathological examination
Index test:peripheral&#32
blood&#32
micRNA

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Hepatitis b related liver cancer patients; 2. Cases of hepatectomy were confirmed as primary liver cancer by postoperative pathological examination; 3. CT examination before surgery; 4. general good, can tolerate surgery.

Exclusion criteria

Exclusion criteria: 1. No follow-up data; 2. There is extrahepatic metastasis; 3. Failure to perform radical surgery; 4. With obvious heart, lung and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
MicroRNA;—

Countries

China

Contacts

Public ContactHe Songqing

Affiliated Hospital of Guilin Medical University

dr_hesongqing@163.com+86 0771-5356568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026